GlassScriptPhysician profile
Ryan T Sacksteder
NPI 1265780555
$2,391.55
in general payments reported to CMS, 2019-2025
20 companies · $307 in 2025
The $307 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $441 · 2020: $204 · 2021: $54.69 · 2022: $93.99 · 2023: $857 · 2024: $434 · 2025: $307.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,598.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,597.80 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $434.20 | 2022-2024 | Vuity, Lumigan, Alphagan P |
| Novartis Pharmaceuticals Corporation | $317.99 | 2019-2023 | |
| Alcon Vision LLC | $257.86 | 2019-2025 | Hydrus Microstent, Rocklatan, Tryptyr |
| Sun Pharmaceutical Industries INC. | $202.72 | 2019-2025 | |
| Glaukos Corporation | $197.10 | 2023-2024 | Istent Infinite Trabecular Micro-Bypass System Model Is3, Idose, Radius |
| Regeneron Healthcare Solutions, INC. | $185.55 | 2021-2025 | Eylea, Eylea Hd |
| New World Medical,INC. | $124.94 | 2024 | Clearpath, Streamline, Kahook Dual Blade |
| Tarsus Pharmaceuticals, INC. | $118.24 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $98.27 | 2019-2021 | |
| Bausch & Lomb Americas INC. | $88.76 | 2023-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $81.92 | 2022-2025 | Tyrvaya, Ryzumvi, Ryzumvi |
| Amgen INC. | $53.59 | 2024-2025 | Tepezza |
| Genentech USA, INC. | $47.90 | 2023 | Vabysmo |
| Shire North American Group INC | $45.70 | 2019 | |
| Kala Pharmaceuticals, INC. | $34.17 | 2020-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $26.68 | 2023 | Tecnis Simplicity |
| Akorn, INC. | $23.90 | 2020 | |
| Ani Pharmaceuticals, INC. | $20.37 | 2025 | Iluvien |
| Allergan, INC. | $20.32 | 2020 | |
| Aerie Pharmaceuticals, INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Sacksteder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.